Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Liver Diseases

  Free Subscription


04.12.2017

2 Am J Pathol
1 Anticancer Res
3 Biochem Biophys Res Commun
1 BMC Cancer
3 BMC Gastroenterol
1 Br J Surg
1 Cancer
2 Cancer Res
2 Clin Res Hepatol Gastroenterol
4 Dig Dis Sci
4 Gastroenterology
1 Gut
13 Hepatology
4 Indian J Gastroenterol
3 J Comput Assist Tomogr
5 J Gastroenterol Hepatol
4 J Hepatol
1 J Pediatr Surg
3 N Engl J Med
2 Oncogene
7 PLoS One
2 Radiology
1 Transplantation


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Am J Pathol

  1. WAN Y, McDaniel K, Wu N, Ramos-Lorenzo S, et al
    Regulation of Cellular Senescence by miR-34a in Alcoholic Liver Injury.
    Am J Pathol. 2017;187:2788-2798.
    PubMed     Text format     Abstract available

  2. DAI Y, Liu L, Zeng T, Liang JZ, et al
    Overexpression of MUC13, a Poor Prognostic Predictor, Promotes Cell Growth by Activating Wnt Signaling in Hepatocellular Carcinoma.
    Am J Pathol. 2017 Nov 21. pii: S0002-9440(17)30418.
    PubMed     Text format     Abstract available


    Anticancer Res

  3. TSUKAMOTO M, Yamashita YI, Imai K, Umezaki N, et al
    Predictors of Cure of Intrahepatic Cholangiocarcinoma After Hepatic Resection.
    Anticancer Res. 2017;37:6971-6975.
    PubMed     Text format     Abstract available


    Biochem Biophys Res Commun

  4. YANG X, Qu K, Tao J, Yin G, et al
    Inhibition of CIP2A attenuates tumor progression by inducing cell cycle arrest and promoting cellular senescence in hepatocellular carcinoma.
    Biochem Biophys Res Commun. 2017 Nov 21. pii: S0006-291X(17)32303.
    PubMed     Text format     Abstract available

  5. ZHAO F, Gong X, Liu A, Lv X, et al
    Downregulation of Nedd4L predicts poor prognosis, promotes tumor growth and inhibits MAPK/ERK signal pathway in hepatocellular carcinoma.
    Biochem Biophys Res Commun. 2017 Nov 22. pii: S0006-291X(17)32318.
    PubMed     Text format     Abstract available

  6. HUANG J, Zheng C, Shao J, Chen L, et al
    Overexpression of eEF1A1 regulates G1-phase progression to promote HCC proliferation through the STAT1-cyclin D1 pathway.
    Biochem Biophys Res Commun. 2017;494.
    PubMed     Text format     Abstract available


    BMC Cancer

  7. WANG G, Dong F, Xu Z, Sharma S, et al
    MicroRNA profile in HBV-induced infection and hepatocellular carcinoma.
    BMC Cancer. 2017;17:805.
    PubMed     Text format     Abstract available


    BMC Gastroenterol

  8. SARANGI AN, Goel A, Singh A, Sasi A, et al
    Faecal bacterial microbiota in patients with cirrhosis and the effect of lactulose administration.
    BMC Gastroenterol. 2017;17:125.
    PubMed     Text format     Abstract available

  9. JAIN A, Chaturvedi R, Kantharia C, Joshi A, et al
    Secondary sclerosing cholangitis in localized hepatobiliary tuberculosis simulating cholangiocarcinoma: a rare case report.
    BMC Gastroenterol. 2017;17:126.
    PubMed     Text format     Abstract available

  10. YAMADA S, Kamada N, Amiya T, Nakamoto N, et al
    Gut microbiota-mediated generation of saturated fatty acids elicits inflammation in the liver in murine high-fat diet-induced steatohepatitis.
    BMC Gastroenterol. 2017;17:136.
    PubMed     Text format     Abstract available


    Br J Surg

  11. ZHANG XF, Beal EW, Bagante F, Chakedis J, et al
    Early versus late recurrence of intrahepatic cholangiocarcinoma after resection with curative intent.
    Br J Surg. 2017 Nov 28. doi: 10.1002/bjs.10676.
    PubMed     Text format     Abstract available


    Cancer

  12. REDDY SK, Boland PM, Nurkin SJ
    Primary tumor resection does not improve survival among patients with unresectable colorectal cancer metastases-But who determines resectability?
    Cancer. 2017 Feb 8. doi: 10.1002/cncr.30595.
    PubMed     Text format    


    Cancer Res

  13. D'COSTA Z, Jones K, Azad A, van Stiphout R, et al
    Gemcitabine-Induced TIMP1 Attenuates Therapy Response and Promotes Tumor Growth and Liver Metastasis in Pancreatic Cancer.
    Cancer Res. 2017;77:5952-5962.
    PubMed     Text format     Abstract available

  14. YAN Q, Jiang L, Liu M, Yu D, et al
    ANGPTL1 Interacts with Integrin alpha1beta1 to Suppress HCC Angiogenesis and Metastasis by Inhibiting JAK2/STAT3 Signaling.
    Cancer Res. 2017;77:5831-5845.
    PubMed     Text format     Abstract available


    Clin Res Hepatol Gastroenterol

  15. LEMOINNE S, Marteau P
    Gut microbial profile in primary biliary cholangitis: Towards bioindicators.
    Clin Res Hepatol Gastroenterol. 2017;41:507-508.
    PubMed     Text format    

  16. MURATORI P, Muratori L
    Autoantibodies in antimithocondrial antibodies negative primary biliary cholangitis.
    Clin Res Hepatol Gastroenterol. 2017;41:e47.
    PubMed     Text format    


    Dig Dis Sci

  17. PRIVITERA G, Spadaro L, Marchisello S, Fede G, et al
    Abnormalities of Lipoprotein Levels in Liver Cirrhosis: Clinical Relevance.
    Dig Dis Sci. 2017 Nov 25. pii: 10.1007/s10620-017-4862.
    PubMed     Text format     Abstract available

  18. GANDINI R, Merolla S, Chegai F, Abrignani S, et al
    Trans-splenic Embolization Plus Partial Splenic Embolization for Management of Variceal Bleeding Due to Left-Sided Portal Hypertension.
    Dig Dis Sci. 2017 Nov 28. pii: 10.1007/s10620-017-4863.
    PubMed     Text format    

  19. SUK KT, Kim MY, Jeong SW, Jang JY, et al
    Impact of Bacterial Translocation on Hepatopulmonary Syndrome: A Prospective Observational Study.
    Dig Dis Sci. 2017 Dec 1. pii: 10.1007/s10620-017-4868.
    PubMed     Text format     Abstract available

  20. LIU H, Hu J, Pan H, Luo D, et al
    CSN5 Promotes Hepatocellular Carcinoma Progression by SCARA5 Inhibition Through Suppressing beta-Catenin Ubiquitination.
    Dig Dis Sci. 2017 Nov 30. pii: 10.1007/s10620-017-4855.
    PubMed     Text format     Abstract available


    Gastroenterology

  21. MOON H, Ju HL, Chung SI, Cho KJ, et al
    Transforming Growth Factor-beta Promotes Liver Tumorigenesis in Mice via Up-regulation of Snail.
    Gastroenterology. 2017;153:1378-1391.
    PubMed     Text format     Abstract available

  22. MARQUARDT JU
    The Role of Transforming Growth Factor-beta in Human Hepatocarcinogenesis: Mechanistic and Therapeutic Implications from an Integrative Multiomics Approach.
    Gastroenterology. 2017 Nov 21. pii: S0016-5085(17)36373.
    PubMed     Text format    

  23. D'MELLO C, Almishri W, Liu H, Swain MG, et al
    Interactions Between Platelets and Inflammatory Monocytes Affect Sickness Behavior in Mice With Liver Inflammation.
    Gastroenterology. 2017;153:1416-1428.
    PubMed     Text format     Abstract available

  24. VANWAGNER LB, Ning H, Allen NB, Ajmera V, et al
    Alcohol Use and Cardiovascular Disease Risk in Patients With Nonalcoholic Fatty Liver Disease.
    Gastroenterology. 2017;153:1260-1272.
    PubMed     Text format     Abstract available


    Gut

  25. CUI CP, Wong CC, Kai AK, Ho DW, et al
    SENP1 promotes hypoxia-induced cancer stemness by HIF-1alpha deSUMOylation and SENP1/HIF-1alpha positive feedback loop.
    Gut. 2017;66:2149-2159.
    PubMed     Text format     Abstract available


    Hepatology

  26. LIN CY
    Statins and risk of decompensation in hepatitis B virus- and hepatitis C virus-related cirrhosis: Methodological issues.
    Hepatology. 2017 Nov 24. doi: 10.1002/hep.29687.
    PubMed     Text format    

  27. LO GH, Reiberger T
    Peptic ulcer bleeding in cirrhotic patients: Is as bad as variceal bleeding?
    Hepatology. 2017 Nov 23. doi: 10.1002/hep.29680.
    PubMed     Text format     Abstract available

  28. ZHANG J, Zhang Q, Lou Y, Fu Q, et al
    HIF-1alpha/IL-1beta signaling enhances hepatoma epithelial-mesenchymal transition via macrophages in a hypoxic-inflammatory microenvironment.
    Hepatology. 2017 Nov 23. doi: 10.1002/hep.29681.
    PubMed     Text format     Abstract available

  29. PENG JM, Bera R, Chiou CY, Yu MC, et al
    Actin cytoskeleton remodeling drives epithelial-mesenchymal transition for hepatoma invasion and metastasis.
    Hepatology. 2017 Nov 23. doi: 10.1002/hep.29678.
    PubMed     Text format     Abstract available

  30. CHANG FM, Wang YP, Lu CL
    Reply: Statins decrease the risk of decompensation in hepatitis B virus- and hepatitis C virus-related cirrhosis: A population-based study.
    Hepatology. 2017 Nov 24. doi: 10.1002/hep.29686.
    PubMed     Text format    

  31. SINGH AK, Rooge SB, Varshney A, Vasudevan M, et al
    Global micro RNA expression profiling in the liver biopsies of Hepatitis B Virus infected patients suggests specific miRNA signatures for viral persistence and hepatocellular injury.
    Hepatology. 2017 Nov 30. doi: 10.1002/hep.29690.
    PubMed     Text format     Abstract available

  32. JI F, Yeo YH, Wei MT, Wei B, et al
    Hepatocellular carcinoma decreases the effectiveness of hepatitis C antiviral treatment: does direct-acting antiviral regimens matter?
    Hepatology. 2017 Dec 1. doi: 10.1002/hep.29701.
    PubMed     Text format    

  33. PETTA S, Valenti L, Tuttolomondo A, Dongiovanni P, et al
    Interferon lambda 4 rs368234815 TT>deltaG variant is associated with liver damage in patients with nonalcoholic fatty liver disease.
    Hepatology. 2017;66:1885-1893.
    PubMed     Text format     Abstract available

  34. BHANJI RA, Narayanan P, Allen AM, Malhi H, et al
    Sarcopenia in hiding: The risk and consequence of underestimating muscle dysfunction in nonalcoholic steatohepatitis.
    Hepatology. 2017;66:2055-2065.
    PubMed     Text format     Abstract available

  35. HU Y, Shin DJ, Pan H, Lin Z, et al
    YAP suppresses gluconeogenic gene expression through PGC1alpha.
    Hepatology. 2017;66:2029-2041.
    PubMed     Text format     Abstract available

  36. LI XF, Chen C, Xiang DM, Qu L, et al
    Chronic inflammation-elicited liver progenitor cell conversion to liver cancer stem cell with clinical significance.
    Hepatology. 2017;66:1934-1951.
    PubMed     Text format     Abstract available

  37. AUGUSTIN S, Pons M, Maurice JB, Bureau C, et al
    Expanding the Baveno VI criteria for the screening of varices in patients with compensated advanced chronic liver disease.
    Hepatology. 2017;66:1980-1988.
    PubMed     Text format     Abstract available

  38. SORIA A, Lapadula G, Fabbiani M, Gori A, et al
    Lower effectiveness of hepatitis C antiviral treatment in patients with hepatocellular carcinoma: Is active tumor the clue?
    Hepatology. 2017 Dec 1. doi: 10.1002/hep.29700.
    PubMed     Text format    


    Indian J Gastroenterol

  39. GOEL A, Arivazhagan K, Sasi A, Shanmugam V, et al
    Translation and validation of chronic liver disease questionnaire (CLDQ) in Tamil language.
    Indian J Gastroenterol. 2017;36:217-226.
    PubMed     Text format     Abstract available

  40. JAIN A, Kahalekar V, Marar S, Gupta D, et al
    Recanalization of TIPSS via transsplenic puncture.
    Indian J Gastroenterol. 2017;36:248-251.
    PubMed     Text format     Abstract available

  41. KUMAR S, Khandelwal N, Kumar A, Yadav K, et al
    Simultaneous living donor liver transplant with sleeve gastrectomy for metabolic syndrome and NASH-related ESLD-First report from India.
    Indian J Gastroenterol. 2017;36:243-247.
    PubMed     Text format     Abstract available

  42. JAGTAP N, Sharma M, Singh J, Tandan M, et al
    Budd-Chiari syndrome: outcomes of endovascular intervention-A single-center experience.
    Indian J Gastroenterol. 2017;36:209-216.
    PubMed     Text format     Abstract available


    J Comput Assist Tomogr

  43. MUELLER J, Stojkovic M, Kauczor HU, Junghanss T, et al
    Performance of Magnetic Resonance Susceptibility-Weighted Imaging for Detection of Calcifications in Patients With Hepatic Echinococcosis.
    J Comput Assist Tomogr. 2017 Nov 16. doi: 10.1097/RCT.0000000000000687.
    PubMed     Text format     Abstract available

  44. COSTA AF, Tremblay St-Germain A, Abdolell M, Smoot RL, et al
    How Do Different Indices of Hepatic Enhancement With Gadoxetic Acid Compare in Predicting Liver Failure and Other Major Complications After Hepatectomy?
    J Comput Assist Tomogr. 2017 Nov 16. doi: 10.1097/RCT.0000000000000691.
    PubMed     Text format     Abstract available

  45. NAM JG, Lee JM, Joo I, Ahn SJ, et al
    Intrahepatic Mass-Forming Cholangiocarcinoma: Relationship Between Computed Tomography Characteristics and Histological Subtypes.
    J Comput Assist Tomogr. 2017 Nov 16. doi: 10.1097/RCT.0000000000000695.
    PubMed     Text format     Abstract available


    J Gastroenterol Hepatol

  46. POLLOCK G, Minuk GY
    Diagnostic Considerations for Cholestatic Liver Disease.
    J Gastroenterol Hepatol. 2017 Jan 20. doi: 10.1111/jgh.13738.
    PubMed     Text format     Abstract available

  47. MORIKAWA M, Suzuki H, Obata-Yasuoka M, Kasai M, et al
    Association of antenatal antithrombin activity with perinatal liver dysfunction: A prospective multicenter study.
    J Gastroenterol Hepatol. 2017;32:1378-1386.
    PubMed     Text format     Abstract available

  48. LOONG TC, Wei JL, Leung JC, Wong GL, et al
    Application of the combined FibroMeter vibration-controlled transient elastography algorithm in Chinese patients with non-alcoholic fatty liver disease.
    J Gastroenterol Hepatol. 2017;32:1363-1369.
    PubMed     Text format     Abstract available

  49. BERTRAIS S, Boursier J, Ducancelle A, Oberti F, et al
    Prognostic durability of liver fibrosis tests and improvement in predictive performance for mortality by combining tests.
    J Gastroenterol Hepatol. 2017;32:1240-1249.
    PubMed     Text format     Abstract available

  50. HIRAOKA A, Otsuka Y, Kawasaki H, Izumoto H, et al
    Impact of muscle volume and function decline in patients undergoing surgical resection for hepatocellular carcinoma.
    J Gastroenterol Hepatol. 2017 Nov 28. doi: 10.1111/jgh.14058.
    PubMed     Text format     Abstract available


    J Hepatol

  51. NOBILI V, Mosca A, Scorletti E, Byrne CD, et al
    Reply 'Energy drinks and risk of non alcoholic steatohepatitis'.
    J Hepatol. 2017 Nov 23. pii: S0168-8278(17)32446.
    PubMed     Text format    

  52. LEE YH, Kim KJ, Yoo ME, Kim G, et al
    Association of nonalcoholic steatohepatitis with subclinical myocardial dysfunction in non-cirrhotic patients.
    J Hepatol. 2017 Nov 23. pii: S0168-8278(17)32448.
    PubMed     Text format     Abstract available

  53. LAU HH, Ng NHJ, Loo LSW, Jasmen J, et al
    The molecular functions of hepatocyte nuclear factors in and beyond the liver.
    J Hepatol. 2017 Nov 23. pii: S0168-8278(17)32451.
    PubMed     Text format     Abstract available

  54. ROBIN S, Buchanan R, Poole R
    Energy drinks and adolescents - a hepatic health hazard?
    J Hepatol. 2017 Nov 22. pii: S0168-8278(17)32444.
    PubMed     Text format    


    J Pediatr Surg

  55. ERGINEL B, Soysal FG, Durmaz O, Celik A, et al
    Long-term outcomes of six patients after partial internal biliary diversion for progressive familial intrahepatic cholestasis.
    J Pediatr Surg. 2017 Nov 23. pii: S0022-3468(17)30711.
    PubMed     Text format     Abstract available


    N Engl J Med

  56. SOOD S, Mingos N, Ross G
    Porphyria.
    N Engl J Med. 2017;377:2100.
    PubMed     Text format    

  57. BISSELL DM, Anderson KE, Bonkovsky HL
    Porphyria.
    N Engl J Med. 2017;377:2101.
    PubMed     Text format    

  58. JARAMILLO-CALLE DA
    Porphyria.
    N Engl J Med. 2017;377:2100-1.
    PubMed     Text format    


    Oncogene

  59. DING D, Huang H, Jiang W, Yu W, et al
    Reticulocalbin-2 enhances hepatocellular carcinoma proliferation via modulating the EGFR-ERK pathway.
    Oncogene. 2017;36:6747-6748.
    PubMed     Text format     Abstract available

  60. NAKATSUKA T, Tateishi K, Kudo Y, Yamamoto K, et al
    Impact of histone demethylase KDM3A-dependent AP-1 transactivity on hepatotumorigenesis induced by PI3K activation.
    Oncogene. 2017;36:6262-6271.
    PubMed     Text format     Abstract available


    PLoS One

  61. XU Y, Li N, Lu M, Dixon E, et al
    The effects of patient cost sharing on inpatient utilization, cost, and outcome.
    PLoS One. 2017;12:e0187096.
    PubMed     Text format     Abstract available

  62. LEE HW, Kim KJ, Jung KS, Chon YE, et al
    The relationship between visceral obesity and hepatic steatosis measured by controlled attenuation parameter.
    PLoS One. 2017;12:e0187066.
    PubMed     Text format     Abstract available

  63. LEE Y, Kwon DJ, Kim YH, Ra M, et al
    HIMH0021 attenuates ethanol-induced liver injury and steatosis in mice.
    PLoS One. 2017;12:e0185134.
    PubMed     Text format     Abstract available

  64. QIU J, Zhou Z, Wang J, Wang Y, et al
    Associations between fatty liver index and asymptomatic intracranial vertebrobasilar stenosis in Chinese population.
    PLoS One. 2017;12:e0187502.
    PubMed     Text format     Abstract available

  65. RICHTIG G, Aigelsreiter A, Schwarzenbacher D, Ress AL, et al
    SOX9 is a proliferation and stem cell factor in hepatocellular carcinoma and possess widespread prognostic significance in different cancer types.
    PLoS One. 2017;12:e0187814.
    PubMed     Text format     Abstract available

  66. LI S, Takahara T, Fujino M, Fukuhara Y, et al
    Astaxanthin prevents ischemia-reperfusion injury of the steatotic liver in mice.
    PLoS One. 2017;12:e0187810.
    PubMed     Text format     Abstract available

  67. KARTOUN U, Corey KE, Simon TG, Zheng H, et al
    The MELD-Plus: A generalizable prediction risk score in cirrhosis.
    PLoS One. 2017;12:e0186301.
    PubMed     Text format     Abstract available


    Radiology

  68. WHITE SB, Kim DH, Guo Y, Li W, et al
    Biofunctionalized Hybrid Magnetic Gold Nanoparticles as Catalysts for Photothermal Ablation of Colorectal Liver Metastases.
    Radiology. 2017;285:809-819.
    PubMed     Text format     Abstract available

  69. YANG X
    Science to Practice: Enhancing Photothermal Ablation of Colorectal Liver Metastases with Targeted Hybrid Nanoparticles.
    Radiology. 2017;285:699-701.
    PubMed     Text format     Abstract available


    Transplantation

  70. PUCHADES L, Chau S, Dodson JA, Mohamad Y, et al
    Association of Cardiac Abnormalities to the Frail Phenotype in Cirrhotic Patients on the Waitlist: From the Functional Assessment in Liver Transplantation (FrAILT) Study.
    Transplantation. 2017 Nov 20. doi: 10.1097/TP.0000000000002025.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Liver Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: